Intelligent Medicine Acquisition Corp. (IQMD)
Intelligent Medicine Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in Bethesda, MD, US. The stock last traded at $11.04, up 7.71% on the session, giving a market capitalisation of $0. On trailing twelve-month figures it carries a trailing P/E of 22.53, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Intelligent Medicine Acquisition Corp. currently has no active business operations. Instead, its primary objective is to seek and finalize a merger, stock exchange, asset acquisition, or other form of business combination with one or more existing companies. The company specifically aims to identify promising business opportunities within the life science sector. Established in 2021, it operates out of Bethesda, Maryland.
Intelligent Medicine Acquisition Corp. is most often compared with the following Financial Services names: